|
AstraZeneca partners with Rigel on asthma drug
CBS News NEW YORK — Rigel Pharmaceuticals Inc. plans to work with AstraZeneca PLC to develop an experimental asthma drug as part of a deal that could be worth … AstraZeneca and Rigel strike asthma deal worth up to $100M AstraZeneca And Rigel Sign Worldwide License Agreement For A … AstraZeneca, Rigel to Develop Asthma Treatment |
View full post on asthma – Google News